Regulus Therapeutics Inc. (RGLS) financial statements (2022 and earlier)

Company profile

Business Address 4224 CAMPUS POINT COURT
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:60,38331,08734,12113,93560,10076,111114,063
Cash and cash equivalents60,38331,08734,12113,93513,51914,94115,960
Short-term investments    46,55561,17098,103
Other undisclosed cash, cash equivalents, and short-term investments    26  
Restricted cash and investments      1,256
Prepaid expense3,0103,3143,9244,1944,8005,600 
Other current assets      759
Other undisclosed current assets1,8422,3292,3621,1661,8365,76318,180
Total current assets:65,23536,73040,40719,29566,73687,474134,258
Noncurrent Assets
Operating lease, right-of-use asset2,564  
Property, plant and equipment281 9217,8069,70811,8305,400
Intangible assets, net (including goodwill)831252665007751,0151,081
Intangible assets, net (excluding goodwill)831252665007751,0151,081
Other noncurrent assets291277487326590342344
Other undisclosed noncurrent assets 472     
Total noncurrent assets:3,2198741,6748,63211,07313,1876,825
TOTAL ASSETS:68,45437,60442,08127,92777,809100,661141,083
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,1222,8593,9147,49912,66913,73511,438
Accounts payable2855351,3211,7145,7435,8402,717
Accrued liabilities8215819174,1844,9415,5776,329
Employee-related liabilities2,0161,7431,6761,6011,9852,3182,392
Deferred revenue  6
Debt 4,65214,63116,57519,859  
Deferred revenue and credits72721,194
Contract with customer, liability2,572
Other liabilities1,2952,9703,047    
Other undisclosed current liabilities8101,097     
Total current liabilities:5,22711,57821,59826,64632,60013,80712,632
Noncurrent Liabilities
Long-term debt and lease obligation7,090      
Long-term debt, excluding current maturities4,673      
Operating lease, liability2,417  
Liabilities, other than long-term debt1,179 4683159,99310,9774,373
Deferred revenue and credits9,99310,8332,065
Contract with customer, liability6
Other liabilities1,179 468309 1442,308
Other undisclosed noncurrent liabilities   6,820 19,802 
Total noncurrent liabilities:8,269 4687,1359,99330,7794,373
Total liabilities:13,49611,57822,06633,78142,59344,58617,005
Stockholders' equity
Stockholders' equity attributable to parent, including:54,95826,02620,015(5,854)35,21656,075124,078
Common stock146672191045353
Additional paid in capital509,660453,002431,305386,860381,104329,496315,673
Accumulated other comprehensive loss    (134)(123)(133)
Accumulated deficit(454,853)(427,045)(411,315)(392,723)(345,858)(273,351)(191,515)
Other undisclosed stockholders' equity attributable to parent524    
Total stockholders' equity:54,95826,02620,015(5,854)35,21656,075124,078
TOTAL LIABILITIES AND EQUITY:68,45437,60442,08127,92777,809100,661141,083

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues 10,0066,83272721,19420,759
Gross profit: 10,0066,83272721,19420,759
Operating expenses(27,816)(24,161)(23,666)(46,835)(70,203)(82,696)(75,517)
Operating loss:(27,816)(14,155)(16,834)(46,763)(70,131)(81,502)(54,758)
Nonoperating expense
(Investment Income, Nonoperating)
      (1,811)
Interest and debt expense(855)(1,808)(2,131)(2,343)(2,723)(1,182)(52)
Loss from continuing operations before equity method investments, income taxes:(28,671)(15,963)(18,965)(49,106)(72,854)(82,684)(56,621)
Other undisclosed income from continuing operations before income taxes864233374459752844855
Loss from continuing operations before income taxes:(27,807)(15,730)(18,591)(48,647)(72,102)(81,840)(55,766)
Income tax expense (benefit)(1) (1)(62)197418
Net loss available to common stockholders, diluted:(27,808)(15,730)(18,592)(48,709)(71,905)(81,836)(55,748)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(27,808)(15,730)(18,592)(48,709)(71,905)(81,836)(55,748)
Comprehensive loss:(27,808)(15,730)(18,592)(48,709)(71,905)(81,836)(55,748)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent    (11)1064
Comprehensive loss, net of tax, attributable to parent:(27,808)(15,730)(18,592)(48,709)(71,916)(81,826)(55,684)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: